CTHRC1 and cancer: In an initial attempt to evaluate CTHRC1 and NFE2L3 as biomarkers for cancer and the obtained antibodies for their identification, the DAS- ELISA was used to measure CTHRC1 and NFE2L3 in colon cancer cells using known colon cancer cell lines as a model.